… over time and the association of trough and peak apixaban … of anticoagulant treatment for
each patient with atrial fibrillation. The … partial thromboplastin time (APTT) (Pathromtin SL) and …

… Apixaban at trough and peak, and to evaluate association between PT DOAC expressed in
Clot Time Ratio CTR and clinical outcomes in patients with atrial … run prothrombin time assays…

… effect of apixaban on endogenous fibrinolysis in patients with non-valvular atrial fibrillation
(NVAF). … to maximal thrombus growth and coagulation, 17 prolonged clotting time and time to …

… observations) favor an association between high rivaroxaban … will be needed for a final
confirmation of this association. … K Antagonist Treatment) trial enrolling apixaban-treated patients …

… without substantial association with lower risk of stroke/SE.18 Elevated F1+2 levels have
been described in stroke patients with AF, and as F1+2 levels reflect thrombin generation they …

… with nonvalvular atrial fibrillation (AF) is still undetermined. The International Society of
Thrombosis and Hemostasis recommends avoiding the use of direct … Partial thromboplastin time …

… Association between the blood apixaban concentration estimated by anti-Xa assay and
prothrombin time with four different reagents. The scatter plot is displayed separately by standard …

… prothrombin time (a measure associated with anticoagulant activity) and higher trough
prothrombin time with apixaban … Society guidelines for the management of atrial fibrillation. Can J …

… PT reagents even in the presence of on-therapy concentrations of apixaban. Therefore, PT
has not been … or assessing the intensity of anticoagulation at on-therapy doses for apixaban. …

… Although patients taking direct oral anticoagulants do not require routine coagulation …
markers such as prothrombin time (PT) and activated partial thromboplastin time (APTT) at peak …